December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Laboratory Corp American Holdings (NY:LH)

337.23 +0.89 (+0.26%)
Streaming Delayed Price Updated: 9:45 AM EDT, Aug 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Laboratory Corp American Holdings

< Previous 1 2 3 4 Next >
News headline image
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs
From Visby Medical
Via Business Wire
News headline image
Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp
From Community Health Systems, Inc.
Via Business Wire
News headline image
Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp
From Community Health Systems, Inc.
Via Business Wire
News headline image
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapies 
From Predictive Oncology Inc.
Via GlobeNewswire
News headline image
Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience
From Praia Health
Via Business Wire
News headline image
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
From NOWDiagnostics, Inc.
Via Business Wire
News headline image
Is This Telehealth Stock a Buy After the Recent Pullback?
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions. 
Via MarketBeat
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
News headline image
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
From Xcell Biosciences Inc.
Via Business Wire
News headline image
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
Laboratory Corp. of America Holdings (NYSE: LH) Records 52-Week High Tuesday Morning
Via Investor Brand Network
News headline image
LifeMD expands telehealth GLP-1weight-loss service with Medifast
LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing 
Via MarketBeat
News headline image
2 aerospace stocks are ready to take flight on the next leg up
The aerospace sector has been red hot in 2023; here are two surging aerospace stocks with the potential to reach even higher altitudes 
Via MarketBeat
News headline image
Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
From Singular Genomics Systems, Inc.
Via GlobeNewswire
News headline image
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
From Enzo Biochem, Inc.
Via GlobeNewswire
News headline image
Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Exact Sciences Serves Investors Exactly What They Wished For
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The 
Via MarketBeat
News headline image
Ovia HealthTM Expands Digital Platform Capabilities to Include Menopause Tracking
From Labcorp
Via Business Wire
News headline image
Labcorp Announces 2022 Fourth Quarter and Full-Year Results
From Labcorp
Via Business Wire
News headline image
Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea
From Labcorp
Via Business Wire
News headline image
Labcorp to Announce Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023
From Labcorp
Via Business Wire
News headline image
Labcorp Declares Quarterly Dividend
From Labcorp
Via Business Wire
News headline image
Thomas Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit
From Labcorp
Via Business Wire
News headline image
Labcorp to Speak at the 41st Annual J.P. Morgan Healthcare Conference
From Labcorp
Via Business Wire
News headline image
Labcorp Opens New Los Angeles Based Laboratory
From Labcorp
Via Business Wire
News headline image
Labcorp to Speak at the Credit Suisse 31st Annual Healthcare Conference
From Labcorp
Via Business Wire
News headline image
Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio
Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022. 
Via MarketBeat
News headline image
Labcorp Announces 2022 Third Quarter Results
From Labcorp
Via Business Wire
News headline image
Labcorp Appoints Google Cloud Executive Kirsten Kliphouse to Its Board of Directors
From Labcorp
Via Business Wire
News headline image
Labcorp Declares Quarterly Dividend
From Labcorp
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.